What is Cybele Microbiome?
Cybele Microbiome is a pioneering entity dedicated to advancing skin health by elucidating the microbiome's critical role in managing inflammation, combating infections, and facilitating wound healing. The company champions the use of ingredients that foster a beneficial microbiome, aiming to enhance product efficacy while minimizing adverse effects. Through strategic collaborations with leading scientists and the execution of rigorous clinical trials, Cybele Microbiome substantiates its claims of delivering tangible improvements in skin health, establishing itself as a frontrunner in the skincare sector by advocating for a balanced microbial ecosystem.
How much funding has Cybele Microbiome raised?
Cybele Microbiome has raised a total of $24K across 1 funding round:
Debt
$24K
Debt (2021): $24K with participation from PPP
Key Investors in Cybele Microbiome
PPP
Public-Private Partnership
What's next for Cybele Microbiome?
With the recent substantial expansion capital, Cybele Microbiome is poised for significant scaling and further research and development. The company's strategic focus on the microbiome's impact on skin health, coupled with its Series B/C stage funding, suggests an accelerated trajectory for product innovation and market penetration. Future endeavors will likely involve expanding their product lines, deepening clinical validation, and potentially forging new strategic partnerships to solidify their leadership in the dermocosmetics industry. This investment will fuel their mission to revolutionize skincare through a deeper understanding of the skin's microbial inhabitants.
See full Cybele Microbiome company page
